
PATIENT ELIGIBILITY CRITERIA Protocol: CT-2024-001 Version: 1.2

INCLUSION CRITERIA:

1. AGE AND CONSENT
    
    - Male or female participants aged 18 to 65 years (inclusive)
    - Able to provide written informed consent
    - Willing to comply with all study procedures
2. DIAGNOSIS
    
    - Confirmed diagnosis of target condition by medical history and examination
    - Symptom duration of at least 6 months
    - Symptom severity score ≥ 15 at screening visit
3. GENERAL HEALTH
    
    - Body Mass Index (BMI) between 18 and 35 kg/m²
    - Adequate hepatic function: ALT and AST ≤ 2.5 × ULN
    - Adequate renal function: eGFR ≥ 60 mL/min/1.73m²
    - Adequate cardiac function: No clinically significant ECG abnormalities
4. CONTRACEPTION (if applicable)
    
    - Women of childbearing potential must use effective contraception
    - Male participants must use barrier contraception if partner is of childbearing potential

EXCLUSION CRITERIA:

1. MEDICAL CONDITIONS
    
    - Pregnant or breastfeeding
    - History of malignancy within 5 years (except treated basal cell carcinoma)
    - Active infection requiring systemic treatment
    - Uncontrolled diabetes (HbA1c > 9%)
    - Uncontrolled hypertension (BP > 160/100 mmHg)
    - History of seizure disorder
2. MEDICATIONS
    
    - Use of prohibited medications within 30 days of screening
    - Current use of immunosuppressive therapy
    - Use of investigational drug within 30 days or 5 half-lives (whichever is longer)
3. ALLERGIES AND SENSITIVITIES
    
    - Known hypersensitivity to study drug or excipients
    - History of severe allergic reactions or anaphylaxis
4. LABORATORY EXCLUSIONS
    
    - Hemoglobin < 10 g/dL
    - Platelet count < 100,000/μL
    - Positive test for HIV, Hepatitis B, or Hepatitis C
    - Positive pregnancy test (for women of childbearing potential)
5. OTHER
    
    - Current participation in another interventional clinical trial
    - Unable or unwilling to comply with study procedures
    - Any condition that, in the investigator's opinion, would compromise safety or data integrity

SCREENING PROCEDURES: All inclusion and exclusion criteria must be assessed at the screening visit. Participants must meet ALL inclusion criteria and NONE of the exclusion criteria to be eligible.
